News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC
Crispin Hiley and Stephanie Saw
Mar 27, 2025, 13:04

Crispin Hiley: Stephanie Saw on Post-Osimertinib Decision Making in EGFR+ NSCLC

Crispin Hiley, UK Clinical Director for Lung Cancer at GenesisCare, shared a post on X:

“Slick discussion of complexity post Osimertinib decision making for patients with EGFR mutation positive NSCLC by Stephanie Saw – it’s a good problem to have in 2025.”

Crispin Hiley

 

cancer Crispin Hiley ELCC 2025 ELCC25 Lung cancer OncoDaily Oncology Stephanie Saw
Special Coverage
Science
Apr 20, 2025, 15:09
Vidith Phillips: AI is flooding healthcare journals, but which papers can you actually trust?
Blog
Apr 20, 2025, 14:56
Yan Leyfman: Promising results from CD19 CAR-NK Cell therapy trial
Blog
Apr 20, 2025, 14:41
Vun-Sin Lim: Vote for Alex Adjei for President-Elect in the 2025 IASLC Board of Directors election
Blog
Apr 20, 2025, 14:19
Michael Sapienza: Proud to welcome leaders and advocates to the 2025 Screen Smart Dinner
Blog
Apr 20, 2025, 14:07
Erika Hamilton: ESMO Breast Cancer 2025 is next month
Cancer Types
Apr 20, 2025, 13:50
Non-Small Cell Lung Cancer: Causes, Symptoms, Diagnosis, Treatment Options, and Latest 2025 Advances in Targeted and Immunotherapy
Blog
Apr 20, 2025, 13:49
Join the global paediatric oncology community in Amsterdam - SIOP
Blog
Apr 20, 2025, 13:31
Estela Rodriguez: It is easy to come up with ideas, hard to implement them
Blog
Apr 20, 2025, 12:54
The invitation to the 6th Annual Meeting in Budapest is waiting for you - SIOP Europe
Blog
Apr 20, 2025, 12:40
Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC - LUNGevity Foundation
Science
Apr 20, 2025, 12:33
Naveen Pemmaraju: Idarubicin and Cytarabine for patients with relapsed and/or refractory AML
Blog
Apr 20, 2025, 12:23
Proud to have over 70 Cardio-Oncology Centers of Excellence around the world - International Cardio-Oncology Society